SAN FRANCISCO — Aquabyte, a startup applying computer vision and machine learning models to dramatically optimize fish farming efficiency, today announced a $3.5 Million Seed Round of funding co-led by Costanoa Ventures and New Enterprise Associates (NEA) with participation from Princeton University and other strategic US and Norwegian investors.
Fish farming is the fastest growing sector of food production in the world with more fish being farmed than beef, representing nearly $160B in yearly production. The industry is rapidly expanding, with experts anticipating that protein consumption will increase world-wide by at least 50 percent by 2050. One of the largest challenges in filling the gap between current supply and projected demand is driving down the cost of feed, which currently represents 50 percent of the cost of fish farming.
"The development of computer vision over the past couple years along with the advent of deep learning has opened up dramatic opportunities to build new vision-related products that can solve very practical, real world problems," said Bryton Shang, Founder and CEO of Aquabyte. "The same computer-vision models I worked on for tissue cancer diagnosis are applicable in a way that can transform the fish farming industry and the future of protein consumption around the world."
Aquabyte's technology will augment the visual IQ of human-operated systems by collecting data with underwater 3D cameras. By installing these cameras in fish farm pens, the technology watches the fish and determines the size of fish/biomass in order to determine the optimal feed quantity. Through the application of its machine learning algorithms, Aquabyte anticipates that this more efficient feeding over a fish's lifetime could result in as much as a 20 to 30 percent decrease in feed cost, which would be tens of billions of dollars saved. Aquabyte is also working on other applications, such as sea lice counting, which accounts for $1 billion in damages in Norway, the largest salmon fish farming country in the world.
Built in Silicon Valley, Aquabyte is first being deployed in Norway. The Company received assistance in establishing its business in the country from Norway's NCE Seafood Innovation cluster. Through this partnership, Aquabyte has set up a number of pilots at local research institutions and farms with sites around the country powered by a team in San Francisco and Bergen, Norway.
"It became very clear to us that applying computer vision to fish farming was a brilliant use of this new technology; we love that Aquabyte makes a difference in the enormous and important challenge of keeping up with the world's demands for fish-based protein," said Greg Sands, Founder and Managing Partner at Costanoa Ventures. "Bryton's deep computer vision background from Princeton and his cross-domain experience with cancer detection and machine learning convinced us that he and his team could really build the right solution."
Aquabyte was founded to bring machine learning and computer vision technologies to the aquaculture industry. Its diverse team of machine learning experts, entrepreneurs, and aquaculture biologists is focused on delivering solutions with a real world impact. Real-time sea lice counting, biomass monitoring, and appetite detection are just a few of the many applications that will be made possible with the Aquabyte system. Aquabyte has offices in San Francisco and Bergen, Norway. Learn More About Aquabyte
About Costanoa Ventures
Costanoa Ventures backs tenacious and thoughtful founders who change how business gets done. Costanoa seeks to be a long-term partner to entrepreneurs building durable companies leveraging data to solve complex business problems. For more information, please visit www.costanoavc.com.
New Enterprise Associates, Inc. (NEA) is a global venture capital firm focused on helping entrepreneurs build transformational businesses across multiple stages, sectors and geographies. With more than $20 billion in cumulative committed capital since the firm's founding in 1977, NEA invests in technology and healthcare companies at all stages in a company's lifecycle, from seed stage through IPO. The firm's long track record of successful investing includes more than 220 portfolio company IPOs and more than 370 acquisitions. For additional information, visit www.nea.com